Jessica lives in Manassas, Virginia, and was diagnosed with Sertoli-Leydig cell ovarian cancer. What has been your frustration in having a rare form of ovarian cancer? It took over 8 years to get diagnosed. Doctor after doctor dismissed me and categorized me into having PCOS. My endocrinologist knew something was wrong but couldn’t figure it … Continued
We hope everyone is keeping cool while feeling the warmth from our ovarian cancer community. And we hope to see many of your faces online this September when we host our Ovarian Cancer National Conference! Read below to find out details, along with other important news. Research Advocacy Patient Support Events Ways to Give Did you … Continued
Have you ever wished you could rewind and replay a confusing conversation with your doctor? Or needed help understanding the options and decisions ahead? Empower yourself with knowledge at our virtual National Conference, taking place September 21-23, 2022. Register today! Sign up to learn the most important information on research, treatment and care, directly from … Continued
OCRA has joined 71 other organizations in signing on to a letter calling for the U.S. Senate to incorporate critical reforms into the Prescription Drug User Fee Act (PDUFA) reauthorization which, if implemented, would improve diversity in clinical trials. These reforms, which are included as provisions in the U.S. House version, would make a number of … Continued
Recent OCRA-funded research has resulted in the creation of a new bioinformatics tool that holds potential for predicting the best treatment combinations for cancer patients. Bioinformatics is a scientific discipline that enables researchers to collect, process and analyze a vast amount of biological and medical data via computers and statistical techniques. In the case of … Continued
Dr. Sandra Cascio of Magee-Womens Research Institute is a 2021 recipient of OCRA’s Early Career Investigative Grant. With her project, “EGFL6 as a New Regulator of Myeloid Cell Expansion and Function in HGSOC,” Dr. Cascio seeks to better understand ovarian tumors’ microenvironments and, ultimately, to overcome ovarian cancer resistance to immunotherapy, opening up a new … Continued
Calling all livestreamers … we need you! In the time of a 4-hour stream, 10 women are diagnosed with ovarian cancer. That’s a new diagnosis every 23 minutes. Join us this August as we partner with Tiltify to help unlock a cure for the #1 cause of gynecologic cancer deaths. Funds raised through #GameOVAR charity … Continued
Dr. Martin Cannon, of University of Arkansas for Medical Sciences (UAMS), is a 2021 recipient of OCRA’s Collaborative Research Development Grant. With his project, “Understanding and Targeting Myeloid Populations in Ovarian Cancer,” Dr. Cannon seeks to better understand the behavior of a type of immune cell that currently helps ovarian cancer tumors grow, in order … Continued
May has been officially recognized as National Cancer Research Month. Of course, at OCRA, every month is research month. Below, we highlight breakthroughs in our understanding and treatment of ovarian cancer, thanks to the ongoing work of our grantees. And be sure to keep scrolling down to discover new ways to get involved and get support! Research … Continued
The following is a press release from Ovarian Cancer Research Alliance and Cancer Research Institute: NEW YORK, May 11, 2022 — The Cancer Research Institute (CRI) and Ovarian Cancer Research Alliance (OCRA) announced today that the first patients have been dosed in their new multi-center platform clinical trial testing novel cancer immunotherapy combinations in patients … Continued
Many exciting updates about progress against ovarian cancer were presented at this year’s Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer — the largest meeting of gynecologic cancer experts in the world. This April, gynecologic oncologist and ovarian cancer expert Dr. Sarah Adams joined OCRA for an interactive webinar reporting on the highlights (in … Continued
Get email updates about research news, action alerts, and ways to join the fight.
